0000000000234603

AUTHOR

Giuseppe Scotti

showing 4 related works from this author

Disruption of White Matter Integrity in Bipolar Depression as a Possible Structural Marker of Illness

2011

Background: Diffusion tensor imaging allows the study of integrity of white matter (WM) tracts. Literature suggests that WM integrity could be altered in bipolar disorder. Heterogeneity of brain imaging methods, the studied samples, and drug treatments make localization, nature, and severity of the WM abnormalities unclear. Methods: We applied tract-based spatial statistics of diffusion tensor imaging measures to compare fractional anisotropy (FA), mean, and radial diffusivity of the WM skeleton in a group of 40 consecutively admitted inpatients affected by a major depressive episode without psychotic features with a diagnosis of bipolar disorder type I and 21 unrelated healthy volunteers f…

AdultMalemedicine.medical_specialtyBipolar DisorderGenu of the corpus callosumImage ProcessingPopulationSpleniumCorpus callosumNerve Fibers MyelinatedWhite matter03 medical and health sciencesComputer-AssistedNerve Fibers0302 clinical medicineInternal medicineFractional anisotropyImage Processing Computer-AssistedmedicineHumanseducationBiological PsychiatryBrain Mappingeducation.field_of_studyAdult; Anisotropy; Bipolar Disorder; pathology; Brain Mapping; Brain; Diffusion Tensor Imaging; Female; Humans; Image Processing; Computer-Assisted; Male; Middle Aged; Nerve Fibers; MyelinatedSuperior longitudinal fasciculusBrainMiddle Aged030227 psychiatry3. Good healthDiffusion Tensor Imagingmedicine.anatomical_structureCardiologyMyelinatedAnisotropypathologyFemalePsychologyNeuroscience030217 neurology & neurosurgeryDiffusion MRIBiological Psychiatry
researchProduct

Neural and genetic correlates of antidepressant response to sleep deprivation - A functional magnetic resonance imaging study of moral valence decisi…

2007

Context: Total sleep deprivation combined with light therapy causes rapid amelioration of bipolar depression. A polymorphism in the promoter for the serotonin transporter influences both antidepressant response and the structure and function of specific brain areas. Objective: To determine whether antidepressant therapy or the genotype of the serotonin transporter influence the pattern of neural response to a task targeting the depressive biases in information processing (moral valence decision). Design: Before-and-after trial studying the biologic correlates of response to treatment. Setting: University hospital. Patients: Twenty inpatients with bipolar depression. Intervention: Repeated t…

Light therapyMaleBipolar DisorderGenotypemedicine.medical_treatmentDecision MakingMoralsJudgmentArts and Humanities (miscellaneous)medicineHumansBipolar disorderSerotonin transporterCerebral CortexChronotherapyPsychiatric Status Rating ScalesSerotonin Plasma Membrane Transport ProteinsSleep disorderDepressive Disorder MajorPolymorphism GeneticbiologyHamilton Rating Scale for DepressionMiddle AgedPhototherapymedicine.diseaseCombined Modality TherapyMagnetic Resonance ImagingHospitalizationOxygenPsychiatry and Mental healthSleep deprivationMoodTreatment Outcomebiology.proteinAntidepressantSleep DeprivationFemalemedicine.symptomPsychologyPsychomotor PerformanceClinical psychology
researchProduct

Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression.

2007

Glutamate is the primary excitatory neurotransmitter of the human brain, and recent findings suggest a role for the glutamatergic system in the pathophysiology and treatment of mood disorders. Single proton magnetic resonance spectroscopy (1H-MRS) was used to study the relative in vivo levels of brain neural metabolites. We evaluated the effect of antidepressant treatments on the relative concentration of unresolved glutamate and glutamine (Glx) with GABA contamination (2.35 ppm peak) using single voxel 1H-MRS at 3.0 Tesla. We studied 19 inpatients (7 males, 12 females) affected by bipolar disorder type 1, current depressive episode without psychotic features, before and after 1 week of tre…

Light therapyAdultMalemedicine.medical_specialtyBipolar DisorderMagnetic Resonance Spectroscopymedicine.medical_treatmentNeuroscience (miscellaneous)Glutamic AcidCreatinechemistry.chemical_compoundInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingBipolar disorderSleep disorderGlutamate receptorBrainMiddle AgedPhototherapymedicine.diseaseCreatineMagnetic Resonance ImagingAntidepressive AgentsPsychiatry and Mental healthSleep deprivationEndocrinologychemistryMood disordersAntidepressantSleep DeprivationFemalemedicine.symptomProtonsPsychologyNeurosciencePsychiatry research
researchProduct

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity

2010

At the crossroad of multiple pathways regulating trophism and metabolism, glycogen synthase kinase (GSK)3 is considered a key factor in influencing the susceptibility of neurons to harmful stimuli (neuronal resilience) and is a target for several psychiatric drugs that directly inhibit it or increase its inhibitory phosphorylation. Inhibition of GSK3 prevents apoptosis and could protect against the neuropathological processes associated with psychiatric disorders. A GSK3-beta promoter single-nucleotide polymorphism (rs334558) influences transcriptional strength, and the less active form was associated with less detrimental clinical features of mood disorders. Here we studied the effect of r…

AdultMaleGenotypeApoptosisNeuropathologyBiologyGrey matterGene Expression Regulation EnzymologicTemporal lobe03 medical and health sciencesBehavioral NeuroscienceSuperior temporal gyrusGlycogen Synthase Kinase 30302 clinical medicineGSK-3GeneticsmedicineHumansGenetic Predisposition to DiseasePromoter Regions GeneticGSK3B030304 developmental biology0303 health sciencesGlycogen Synthase Kinase 3 betaPolymorphism GeneticGenetic VariationBrodmann area 21medicine.diseaseTemporal LobeEnzyme Activationmedicine.anatomical_structureNeurologySchizophreniaChronic DiseaseNerve DegenerationSchizophreniaFemaleAtrophyNeuroscience030217 neurology & neurosurgeryGenes, Brain and Behavior
researchProduct